RevOpsis Therapeutics Secures $1.8M NEI SBIR Grant to Propel Innovative Ophthalmic Therapies

In a significant advancement for ophthalmic medicine, RevOpsis Therapeutics, a pioneering biopharmaceutical firm, has been awarded a Small Business Innovation Research (SBIR) grant exceeding $1.8 million from the National Eye Institute (NEI), part of the National Institutes of Health (NIH). This funding will bolster the development of their lead asset, RO-104, aimed at treating neovascular…

Read More

Beacon AI Secures $15M in Series A Funding to Revolutionize Aviation Safety

In a significant stride toward transforming aviation safety and efficiency, Beacon AI has announced the successful closure of a $15 million Series A funding round, led by Costanoa Ventures. The round saw substantial participation from Scout Ventures, along with contributions from prominent investors, including Sam Altman and JetBlue Ventures. This latest infusion of capital elevates…

Read More

Monument Therapeutics Secures £1M Investment to Advance Schizophrenia Treatment Program

Monument Therapeutics, a leader in precision neuroscience, has announced a significant £1 million equity investment from the Forster Foundation, a charitable organization. This new funding builds on previous equity and non-dilutive investments disclosed in April 2024, and will support the clinical development of MT1988, an innovative treatment targeting cognitive symptoms of schizophrenia. Cognitive impairments associated…

Read More

Neuron7.ai Raises $44 Million in Series B Funding to Revolutionize Service Resolution with AI

Neuron7.ai, a trailblazer in Service Resolution Intelligence, has successfully secured $44 million in Series B funding led by Smith Point Capital, founded by former Salesforce Co-CEO Keith Block. This financing round also saw participation from existing investors Nexus Venture Partners and Battery Ventures, raising the total capital raised to over $63 million. The impressive growth…

Read More

Parakeet Health Unveils Generative AI Voice Platform with $3 Million Seed Funding to Revolutionize Patient Engagement

In a significant stride toward enhancing patient-provider communication, Parakeet Health has launched its innovative generative AI voice platform, a move bolstered by $3 million in seed funding led by Canvas Ventures. This pioneering solution is set to transform how healthcare providers manage patient interactions, aiming to improve engagement while alleviating the burdens often faced by…

Read More

Port Secures $35 Million in Series B Funding to Elevate Internal Developer Portals

Port, a trailblazer in the realm of internal developer portals, has successfully raised $35 million in a Series B funding round, bringing its total funding to $58 million. The round was spearheaded by Accel, with notable participation from Bessemer Venture Partners, alongside existing investors including Team8 and TLV Partners. This substantial investment follows Port’s impressive…

Read More

Ghost Secures $40 Million Series C Funding Led by L Catterton to Revolutionize B2B Inventory Management

In a significant boost for the B2B marketplace, Ghost, which connects top brands with retailers, has announced the completion of a $40 million Series C funding round led by global investment firm L Catterton. This funding round also saw participation from existing investors including USV, Cathay Innovation, Equal Ventures, and Eniac. Ghost’s innovative tech-enabled marketplace…

Read More

Alchemy Secures $31M in Seed Funding to Revolutionize Pharmacy Services for HIV Clinics

In a groundbreaking move aimed at enhancing healthcare accessibility for underserved communities, Alchemy has successfully closed a $31 million seed financing round. The funding, led by Andreessen Horowitz (“a16z”) Bio + Health, garnered support from notable investors, including NBA legend Earvin “Magic” Johnson, Sandberg Bernthal Venture Partners, Banc of California, and existing backers such as…

Read More

Galileo Secures $45 Million in Series B Funding to Enhance AI Evaluation for Enterprises

In a significant advancement for the realm of generative AI, Galileo has announced the completion of a $45 million Series B funding round, led by Scale Venture Partners. This marks the largest Series B investment to date in AI evaluation and observability, following an impressive 834% revenue growth for the company in 2024 and its…

Read More